Trial Profile
An Open-Label Study to Explore the Clinical Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant in HIV-HCV infected patients Studio in aperto per valutare l'efficacia clinica di sofosbuvir, somministrato in associazione a ribavirina in fase pre-trapianto, nel prevenire recidive post-trapianto dell'infezione da virus dell'epatite C (HCV) in soggetti con infezione HIV-HCV.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Feb 2018
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms SOFT-preOLT
- Sponsors Gilead Sciences
- 15 Feb 2018 This trial has been completed in Italy, according to European Clinical Trials Database
- 07 Sep 2014 New trial record